These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31735930)

  • 1. Adherence of Drug Promotional Literatures Distributed by Pharmaceutical Companies to World Health Organization Ethical Criteria for Medicinal Drug Promotion.
    Prasad P; Bajracharya SR; Deo S; Lamichhane S; Pradhan PMS; Ghimire R; Pokharel A
    J Nepal Health Res Counc; 2019 Nov; 17(3):345-350. PubMed ID: 31735930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribers Perception on Drug Promotional Literatures in A Tertiary Care Hospital in Nepal.
    Prasad P; Mudvari A; Ghimire R; Karki N; Yadav D; Shah S; Gyanwali P
    J Nepal Health Res Counc; 2021 Apr; 19(1):19-25. PubMed ID: 33934127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pharmaceutical promotion on prescribers in Jordan.
    Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
    Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What patients think about promotional activities of pharmaceutical companies in Turkey.
    Semin S; Güldal D; Ozçakar N; Mevsim V
    Pharm World Sci; 2006 Aug; 28(4):199-206. PubMed ID: 17066242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of drug promotional materials in a hospital setting in Nepal.
    Alam K; Shah AK; Ojha P; Palaian S; Shankar PR
    South Med Rev; 2009 Apr; 2(1):2-6. PubMed ID: 23093870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Drug and Herbal Medicinal Promotions on Social Media During the COVID-19 Pandemic in Relation to World Health Organization Ethical Criteria and South African Health Products Regulatory Authority Guidelines in South Africa: Cross-Sectional Content Analysis.
    Chimukuche RS; Ndlazi J; Mtolo LT; Bird K; Seeley J
    Online J Public Health Inform; 2024 Sep; 16():e58378. PubMed ID: 39293046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the reliability and accuracy of the promotional brochures for the generic pharmaceutical companies in Iraq using World Health Organization guidelines.
    Mikhael EM
    J Pharm Bioallied Sci; 2015; 7(1):65-8. PubMed ID: 25709340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?
    Mohiuddin M; Rashid SF; Shuvro MI; Nahar N; Ahmed SM
    BMC Med Ethics; 2015 Dec; 16(1):80. PubMed ID: 26625723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of promotional advertisements of drugs in a medical journal: an ethics perspective.
    Nath S; Bhowmick S; Dutta T; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sarkar M; Ram AK; Mukherjee PK
    Indian J Med Ethics; 2014; 11(4):237-41. PubMed ID: 25377037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influences of drug companies' advertising programs on physicians.
    Güldal D; Semin S
    Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of drug promotional literatures published in scientific medical journals.
    Vachhani PM; Solanki MN; Desai MK
    J Pharm Bioallied Sci; 2016; 8(3):248-52. PubMed ID: 27413355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Critical Review of the Drug Promotional Literature Published in Scientific Medical Journals and Available at Outpatient Departments: A Cross-Sectional Observational Study.
    Vivek K; Deolekar P; Naseem A; Langade DG; Yadav P
    Cureus; 2022 Nov; 14(11):e31283. PubMed ID: 36514598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of rationality of promotional drug literature using World Health Organization guidelines.
    Mali SN; Dudhgaonkar S; Bachewar NP
    Indian J Pharmacol; 2010 Oct; 42(5):267-72. PubMed ID: 21206615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The attitude and acceptability towards medical promotional tools and their influence on physicians' prescribing practices in Jordan and Iraq: a cross-sectional study.
    Ali KE; Naser AY; Al-Rousan R; Alwafi H; AbuAlhommos AK; Alsairafi ZK; Salawati EM; Samannodi M; Dairi MS
    BMC Health Serv Res; 2022 Jan; 22(1):105. PubMed ID: 35078461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug promotion practices: A review.
    Jacob NT
    Br J Clin Pharmacol; 2018 Aug; 84(8):1659-1667. PubMed ID: 29349812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.
    Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B
    Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug advertising and promotion: regulations and extent of compliance in five Latin American countries].
    Vacca C; Vargas C; Cañás M; Reveiz L
    Rev Panam Salud Publica; 2011 Feb; 29(2):76-83. PubMed ID: 21437364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.